Cargando…
Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons
INTRODUCTION: Synaptic dysfunction and intracellular transport defects are early events in Alzheimer’s disease (AD). Extracellular amyloid β (Aβ) oligomers cause spine alterations and impede the transport of proteins and organelles such as brain-derived neurotrophic factor (BDNF) and mitochondria th...
Autores principales: | Umeda, Tomohiro, Ramser, Elisa M., Yamashita, Minato, Nakajima, Koichi, Mori, Hiroshi, Silverman, Michael A., Tomiyama, Takami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546183/ https://www.ncbi.nlm.nih.gov/pubmed/26293809 http://dx.doi.org/10.1186/s40478-015-0230-2 |
Ejemplares similares
-
Erratum: Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons
por: Umeda, T, et al.
Publicado: (2016) -
Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
por: Umeda, Tomohiro, et al.
Publicado: (2021) -
Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
por: Umeda, Tomohiro, et al.
Publicado: (2022) -
Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons
por: Ramser, Elisa M., et al.
Publicado: (2013) -
Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice
por: Umeda, Tomohiro, et al.
Publicado: (2021)